Literature DB >> 2818579

Amphotericin B and Nystatin show different activities on sterol-free vesicles.

B S Whyte1, R P Peterson, S C Hartsel.   

Abstract

It has generally been assumed that the polyene antibiotics Nystatin and Amphotericin B cause membrane damage by the same mechanism. However, using kinetic fluorescence methods we have found that AmB and Nystatin have very different activities on sterol-free dioleoyl phosphatidylcholine and egg phosphatidylcholine small unilamellar vesicles. At very low AmB concentrations (less than 1/1000 lipids in egg phosphatidylcholine) significant K+ permeability enhancement is observed. However, even at very high Nystatin to lipid ratios (1/100) very little K+ current is induced, particularly in dioleoyl phosphatidylcholine vesicles. The novel technique described here uses a K+/H+ exchange mechanism to detect minute transmembrane K+ currents by monitoring internal membrane vesicle pH changes with pyranine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818579     DOI: 10.1016/0006-291x(89)91503-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Effect of membrane structure on the action of polyenes II: nystatin activity along the phase diagram of ergosterol- and cholesterol-containing POPC membranes.

Authors:  J González-Damián; I Ortega-Blake
Journal:  J Membr Biol       Date:  2010-09-25       Impact factor: 1.843

2.  Na+, K+ and Cl- selectivity of the permeability pathways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics.

Authors:  S C Hartsel; S K Benz; W Ayenew; J Bolard
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

3.  Use of artificial ion channels for quasi-intracellular recording of cerebral cortex neuron activity.

Authors:  D N Lenkov
Journal:  Neurosci Behav Physiol       Date:  1997 Nov-Dec

4.  Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation.

Authors:  Ana Coutinho; Liana Silva; Alexander Fedorov; Manuel Prieto
Journal:  Biophys J       Date:  2004-08-17       Impact factor: 4.033

5.  Salvage treatment with amphotericin B in progressive human alveolar echinococcosis.

Authors:  Stefan Reuter; Andreas Buck; Olaf Grebe; Karin Nüssle-Kügele; Peter Kern; Burkhard J Manfras
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

6.  Effect of amphotericin B on larval growth of Echinococcus multilocularis.

Authors:  Stefan Reuter; Marion Merkle; Klaus Brehm; Peter Kern; Burkhard Manfras
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 7.  The Role of Signaling via Aqueous Pore Formation in Resistance Responses to Amphotericin B.

Authors:  B Eleazar Cohen
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

8.  Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis.

Authors:  Camila Arruda Saldanha; Mônica Pereira Garcia; Diego Cesar Iocca; Luciana Guilherme Rebelo; Ana Camila Oliveira Souza; Anamélia Lorenzetti Bocca; Maria de Fátima Menezes Almeida Santos; Paulo Cesar Morais; Ricardo Bentes Azevedo
Journal:  PLoS Negl Trop Dis       Date:  2016-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.